Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2013; 19(35): 5775-5786
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5775
Published online Sep 21, 2013. doi: 10.3748/wjg.v19.i35.5775
Ref. | No. of patients | Technique | Outcome | Complications | Follow-up (mo) |
van Erpecum et al[35] | 15 | Open fenestration | 0% symptom recurrence | One mortality | Mean of 48 |
Kabbej et al[37] | 13 | Lap fenestration | 72% symptom recurrence | 54% morbidity | Mean follow-up 26 |
Gigot et al[38] | 10 | Open fenestration | 11% symptom recurrence | 60% morbidity | 73 mean follow-up |
van Keimpema et al[82] | 12 | Lap fenestration | Reduction in liver volume by 12.5% | Bile leak, vena cava occlusion and sepsis | - |
Pirenne et al[92] | 4 | Lap fenestration | 100% symptom relief | 50% cyst recurrence | - |
Liska et al[95] | 7 | Lap fenestration plus open | - | No mortality | Mean 41 |
Bai et al[96] | 10 | Lap fenestration | Symptom and cyst recurrence in 20% | 3 patients with minor complications. No mortality | Mean of 57 |
Palanivelu et al[97] | 4 | Lap fenestration | 100% cyst recurrence | - | - |
Garcea et al[98] | 6 | Lap/Open fenestration | 16.7% symptom recurrence, 33.3% cyst recurrence | 50% morbidity | 5-36 |
Neri et al[99] | 3 | Lap fenestration | 100% symptom relief | 50% morbidity | - |
Kornprat et al[100] | 8 | Lap fenestration | 0% symptom recurrence | - | - |
Robinson et al[101] | 11 | Lap fenestration | 54.5% symptom recurrence | - | - |
Fiamingo et al[102] | 6 | Lap fenestration | 30% symptom recurrence | 50% morbidity | 1-64 |
Tocchi et al[103] | 18 | Lap/open fenestration | - | - | - |
Koperna et al[104] | 39 | Open fenestration (n = 34); Lap (n = 5) | 21% symptom recurrence | - | 75 mean follow-up |
Morino et al[105] | 7 | Lap fenestration | 40% symptom recurrence | 44% morbidity rate | - |
Farges et al[106] | 13 | Open fenestration | 23% symptom recurrence | 69% morbidity | 84 follow-up |
Ueno et al[118] | 13 | Open fenestration (n = 6); Lap (n = 13) | 71% symptom recurrence | 30% morbidity | 37 mean follow-up |
- Citation: Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol 2013; 19(35): 5775-5786
- URL: https://www.wjgnet.com/1007-9327/full/v19/i35/5775.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i35.5775